Old Web
English
Sign In
Acemap
>
authorDetail
>
A. Gaudy
A. Gaudy
Celgene
Medicine
Cereblon
Immunology
Multiple myeloma
Neutropenia
3
Papers
3
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
IBERDOMIDE (CC-220) IS PHARMACODYNAMICALLY ACTIVE AND HAS DOSE-DEPENDENT IMMUNOSTIMULATORY ACTIVITY IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS IRRESPECTIVE OF PRIOR IMID DRUG TREATMENT: PF559
2019
Michael Amatangelo
A. Gaudy
Chad C. Bjorklund
Maria Wang
Suzana Couto
William E. Pierceall
N W C J van de Donk
Sagar Lonial
Rakesh Popat
Jeffrey A. Zonder
M. C. Minnema
Jeremy T. Larsen
P. Sonneveld
Tuong-Vi Nguyen
Kevin Hong
Tsvetan Biyukov
Anjan Thakurta
Show All
Source
Cite
Save
Citations (0)
SAT0225 Cereblon modulator CC-220 decreases naÏve and memory B cells and plasmacytoid dendritic cells in systemic lupus erythematosus (SLE) patients: exposure-response results from a phase 2A proof of concept study
2017
Annals of the Rheumatic Diseases
A. Gaudy
Ying Ye
Shimon Korish
Douglas Hough
Michael Weiswasser
S Choi
Richard Furie
Victoria P. Werth
Peter H. Schafer
Show All
Source
Cite
Save
Citations (3)
AB0040 Effects of CC-220, A CRL4 Cereblon E3 Ubiquitin Ligase Modulator, on Immune Responses
2015
Annals of the Rheumatic Diseases
Ying Ye
Peter H. Schafer
Michael Thomas
D. Weiss
A. Gaudy
Z. Yang
Liangang Liu
E. O'Mara
Maria Palmisano
Show All
Source
Cite
Save
Citations (0)
1